FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049250982> ?p ?o ?g. }

• W3049250982 abstract "Abstract Background Mucosal immunity, including secretory IgA (sIgA), plays an important role in early defenses against respiratory pathogens. Salivary testing, the most convenient way to measure sIgA, has been used to characterize mucosal immune responses to many viral infections including SARS, MERS, influenza, HIV, and RSV. However, its role has not yet been characterized in the COVID-19 pandemic. Here, we report development and validation of a rapid immunoassay for measuring salivary IgA against the SARS-CoV-2 virus, and report quantitative results in both pre-COVID-19 and muco-converted subjects. Methods We developed and refined a specific test for salivary IgA against SARS-CoV-2 on the Brevitest platform, a rapid immunoassay system designed for point-of-care use. A qualitative test was validated as per FDA guidelines with saliva obtained from subjects prior to the emergence of COVID-19, and from PCR-confirmed COVID-19 patients. We also generated a quantitative measure of anti-SARS-CoV-2 salivary IgA. Time taken for saliva self-collection was measured and its ease-of-use assessed. Results We successfully validated a qualitative salivary assay for SARS-CoV-2 IgA antibodies, with positive and negative predictive values of 92% and 97%, respectively, and no observable cross-reactivity with any of seven potential confounders. Pre-COVID-19 saliva samples showed an 8-fold range of IgA concentrations, suggesting a broad continuum of natural antibody resistance against the novel virus, though at levels lower than that observed in COVID-19 PCR-confirmed subjects. Samples from muco-positive subjects also shown a ~9-fold variation in salivary IgA levels, with elevated salivary IgA observed beyond three months after onset of symptoms. We observed a correlation (r=0.4405) between salivary IgA levels and COVID-19 disease severity. In anecdotal observations, we observed individuals who exhibited antibodies early in the course of their disease, contemporaneously with a positive PCR test, as well as individuals who muco-converted despite no known direct exposure to a COVID-19 patient, no symptoms, and negative molecular and/or serum antibody tests. Salivary collection took 5-10 minutes, and was reported as being easy (mean of 1.1 on a scale of 1 to 10). Implications Mucosal immunity, including secretory IgA, plays an important role in host defense against respiratory pathogens, and our early data suggest it may do so in COVID-19. Salivary IgA, an accessible marker of mucosal immunity, may be a useful indicator of several key parameters including individual and community immune response, disease severity, clinical risk, and herd immunity. The non-invasive nature and ease of saliva collection facilitates its potential use as a biomarker for ongoing patient assessment and management, as well as a community surveillance tool. By measuring mucosal immune responses directly and systemic immune responses indirectly, salivary IgA could be useful in developing and deploying a vaccine(s) against COVID-19. Quantitative IgA assessment could also potentially serve as a tool to segment the population into different risk categories and inform individual and collective decisions relating to appropriate activities and vaccine prioritization/delivery. These data reinforce the importance of further investigation into the role of mucosal immunity and IgA in host responses against COVID-19." @default.
• W3049250982 created "2020-08-21" @default.
• W3049250982 creator A5001750709 @default.
• W3049250982 creator A5002323793 @default.
• W3049250982 creator A5002342819 @default.
• W3049250982 creator A5004045533 @default.
• W3049250982 creator A5013602233 @default.
• W3049250982 creator A5019575895 @default.
• W3049250982 creator A5023977164 @default.
• W3049250982 creator A5039171271 @default.
• W3049250982 creator A5045770605 @default.
• W3049250982 creator A5047307094 @default.
• W3049250982 creator A5051600461 @default.
• W3049250982 creator A5070111232 @default.
• W3049250982 creator A5078492184 @default.
• W3049250982 date "2020-08-11" @default.
• W3049250982 modified "2023-10-14" @default.
• W3049250982 title "Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19" @default.
• W3049250982 cites W127767540 @default.
• W3049250982 cites W1481879298 @default.
• W3049250982 cites W1580742681 @default.
• W3049250982 cites W1593105372 @default.
• W3049250982 cites W1974819708 @default.
• W3049250982 cites W1990711002 @default.
• W3049250982 cites W1991717485 @default.
• W3049250982 cites W1997287927 @default.
• W3049250982 cites W2003355468 @default.
• W3049250982 cites W2011306933 @default.
• W3049250982 cites W2021503322 @default.
• W3049250982 cites W2033379572 @default.
• W3049250982 cites W2034996214 @default.
• W3049250982 cites W2037706668 @default.
• W3049250982 cites W2038081872 @default.
• W3049250982 cites W2049323213 @default.
• W3049250982 cites W2053357534 @default.
• W3049250982 cites W2060565977 @default.
• W3049250982 cites W2074655041 @default.
• W3049250982 cites W2094834014 @default.
• W3049250982 cites W2095292190 @default.
• W3049250982 cites W2106845589 @default.
• W3049250982 cites W2110318148 @default.
• W3049250982 cites W2116100423 @default.
• W3049250982 cites W2135388445 @default.
• W3049250982 cites W2140274822 @default.
• W3049250982 cites W2147193679 @default.
• W3049250982 cites W2171257320 @default.
• W3049250982 cites W2418209680 @default.
• W3049250982 cites W2746600415 @default.
• W3049250982 cites W2804122286 @default.
• W3049250982 cites W2804581180 @default.
• W3049250982 cites W2805402872 @default.
• W3049250982 cites W2955956464 @default.
• W3049250982 cites W2959793769 @default.
• W3049250982 cites W3001638293 @default.
• W3049250982 cites W3001897055 @default.
• W3049250982 cites W3002108456 @default.
• W3049250982 cites W3004280078 @default.
• W3049250982 cites W3008443627 @default.
• W3049250982 cites W3011176674 @default.
• W3049250982 cites W3013653866 @default.
• W3049250982 cites W3014442018 @default.
• W3049250982 cites W3015777733 @default.
• W3049250982 cites W3017346460 @default.
• W3049250982 cites W3019171825 @default.
• W3049250982 cites W3019663170 @default.
• W3049250982 cites W3023996322 @default.
• W3049250982 cites W3025320502 @default.
• W3049250982 cites W3029201461 @default.
• W3049250982 cites W3035231413 @default.
• W3049250982 cites W4238786099 @default.
• W3049250982 cites W4249567188 @default.
• W3049250982 cites W46942601 @default.
• W3049250982 cites W1976529212 @default.
• W3049250982 doi "https://doi.org/10.1101/2020.08.07.20170258" @default.
• W3049250982 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7430621" @default.
• W3049250982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32817976" @default.
• W3049250982 hasPublicationYear "2020" @default.
• W3049250982 type Work @default.
• W3049250982 sameAs 3049250982 @default.
• W3049250982 citedByCount "48" @default.
• W3049250982 countsByYear W30492509822020 @default.
• W3049250982 countsByYear W30492509822021 @default.
• W3049250982 countsByYear W30492509822022 @default.
• W3049250982 countsByYear W30492509822023 @default.
• W3049250982 crossrefType "posted-content" @default.
• W3049250982 hasAuthorship W3049250982A5001750709 @default.
• W3049250982 hasAuthorship W3049250982A5002323793 @default.
• W3049250982 hasAuthorship W3049250982A5002342819 @default.
• W3049250982 hasAuthorship W3049250982A5004045533 @default.
• W3049250982 hasAuthorship W3049250982A5013602233 @default.
• W3049250982 hasAuthorship W3049250982A5019575895 @default.
• W3049250982 hasAuthorship W3049250982A5023977164 @default.
• W3049250982 hasAuthorship W3049250982A5039171271 @default.
• W3049250982 hasAuthorship W3049250982A5045770605 @default.
• W3049250982 hasAuthorship W3049250982A5047307094 @default.
• W3049250982 hasAuthorship W3049250982A5051600461 @default.
• W3049250982 hasAuthorship W3049250982A5070111232 @default.
• W3049250982 hasAuthorship W3049250982A5078492184 @default.
• W3049250982 hasBestOaLocation W30492509821 @default.
• W3049250982 hasConcept C126322002 @default.

• next